RPE65 and retinal degeneration: A study by Cideciyan et al. demonstrates advancing retinal degeneration despite visual improvement after gene therapy for RPE65-LCA, and suggests the need for a combinatorial strategy to improve vision function in short term but also to slow retinal degeneration in the long term [20].